Search Results 381-390 of 24281 for B cell lymphomas
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...
... B-cell non-Hodgkin lymphoma (NHL), and in previously untreated participants with diffuse large B-cell lymphoma (DLBCL). Everolimus and Lenalidomide in ...
She is board certified in internal medicine, medical oncology, and hematology, and has a special interest in T-cell lymphomas ... B-cell lymphoma · Cutaneous t- ...
Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity Cancer Res.2012;72:(17)4440-8. Horna P, Olteanu H ...
Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...
Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...
Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients. ... B-cell lymphoma. Blood Cancer J ...
... B-Cell Lymphoma (DLBCL). A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!